Syneos Health and KX team on predictive analytics, AI and ML

Syneos Health (SYNH) announced a strategic partnership with KX, maker of kdb time series database and analytics engine. The partnership will deliver data-driven predictive analytics, Artificial Intelligence and Machine Learning capabilities to help customers address complex healthcare decisions via the industry’s first Data Time house, a new class of data and AI management engine designed for temporal data generated by digital transformation. Benefits include real-time engagement and faster and more accurate decision-making related to drug trial site selection. Through the collaboration, Syneos Health and KX will improve clinical trial efficiency, reduce costs and speed time to market for life-changing therapies for patients. The partnership will empower biopharmaceutical customers to better solve complex healthcare decisions through data – meeting them wherever they are, and supporting their needs, across the clinical to commercial continuum. Our KX partnership advances our ability to deliver data-driven insights and AI-enabled solutions, helping biopharma customers solve their most complex clinical development and commercialization challenges," said Baba Shetty, President, Technology and Data Solutions, Syneos Health. Earlier this week, Syneos Health announced a strategic partnership with Microsoft (MSFT) to accelerate AI across the clinical to commercial continuum. The company’s collaboration with KX amplifies this work as both parties utilize Microsoft’s Azure technology to bring the potential benefits of AI, ML and tech-enabled solutions to customers, providing them with data-driven insights that will enhance performance, effectiveness and efficiency across the asset development lifecycle.